SciELO - Scientific Electronic Library Online

 
vol.106 issue2Difficult tracheal tube insertion: A new phraseologyThe UCT class of 2000 reunion author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • On index processSimilars in Google

Share


SAMJ: South African Medical Journal

On-line version ISSN 2078-5135
Print version ISSN 0256-9574

SAMJ, S. Afr. med. j. vol.106 n.2 Pretoria Feb. 2016

http://dx.doi.org/10.7196/SAMJ.2016.V106I2.9679 

CORRESPONDENCE

 

Who will guard the guards? Medical leadership and conflict of interest in South African healthcare

 

 

To the Editor: Conflicts of interest (COI) arising from the interaction of the pharmaceutical industry with doctors have been described in an SAMJ editorial.[1] The common interests in patient wellbeing, shared by doctors and the pharmaceutical industry, will conflict with the pharmaceutical industry's wish to sell their products and influence doctors' behaviour.

A number of important measures to deal with COI are described in the editorial, including disclosure of COI, creating awareness of the problem, academic discussions and fostering professionalism by practitioners.

A further measure that should be included to complement the above is the use of clinical protocols (standardised care guidelines).

This approach avoids negative influences on treatment recommendations by excluding outside sources with different agendas and avoiding financial inducements. Other potential negative influences that may arise from discrimination because of age, sex, race, sexual orientation, disease and disability may also be avoided.

This approach also reinforces positive influences through transparency and peer review and having both academic and pragmatic input.

Clinical guidelines have become widely available, for good medical[2] and economic reasons A standardised approach allows for a body of experience to be reviewed individually, regionally or nationally to evaluate its effectiveness. For example, in oncology, cancer of the lung and oesophagus presents and responds differently to treatment in South Africa, Asia and Europe. Available resources will also be considered, as well as the marginal gain for new but costly treatments.

Clinical guidelines reduce COI and facilitate the documentation of a body of experience on which to base patient care in the future.

Raymond P Abratt

Head of Clinical Governance, Independent Clinical Oncology Network, and Professor Emeritus, University of Cape Town, South Africa. raymond.abratt@cancernet.co.za

 

References

1. Parish A, Blockman M. Who will guard the guards? Medical leadership and conflict of interest in South African healthcare. S Afr Med J 2014;104(11):757-758. [http://dx.doi.org/10.7196/SAMJ.8546]        [ Links ]

2. Grimshaw JM1, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342(8883):1317-1322. [http://dx.doi.org/10.1016/0140-6736(93)92244-N]        [ Links ]

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License